From Inuit to implementation: Omega-3 fatty acids come of age

Mayo Clinic Proceedings

Volumn 75, Issue 6, 2000, Pages 607-614

  O'Keefe Jr , James H ^a,b   Harris, William S ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b Cardiovascular Consultants Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINOLENIC ACID; OMEGA 3 FATTY ACID;

ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; DRUG MECHANISM; HEART MUSCLE FIBER MEMBRANE; HEART PROTECTION; HUMAN; PROGNOSIS; REVIEW; RISK BENEFIT ANALYSIS; SUDDEN DEATH; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034045541     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.6.607     Document Type: Review

References (85)

1. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 1993;269:3015-3023.
2. Watts GF, Lewis B, Brunt JN, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study. Lancet. 1992;339:563-569.
3. Corr LA, Oliver MF. The low fat/low cholesterol diet is ineffective. Eur Heart J. 1997; 18:18-22.
4. Bang HO, Dyerberg J. Lipid metabolism and ischémie heart disease in Greenland Eskimos. In: Draper H, ed. Advances in Nutrition Research. New York, NY: Plenum Press; 1980:1-22.
5. Kagawa Y, Nishizawa M, Suzuki M, et al. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J Nut r Sei Vitaminol. 1982;28:441-453.
6. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-1209.
7. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997; 336:1046-1053.
8. Dolecek TA. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial. Proc Soc Exp Biol Med. 1992;200: 177-182.
9. Burchfiel CM, Reed DM, Strong JP, Sharp DS, Chyou PH, Rodriguez BL. Predictors of myocardial lesions in men with minimal coronary atherosclerosis at autopsy: the Honolulu Heart Program. Ann Epidemiol. 1996;6:137-146.
10. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. JAm Coll Cardiol. 1995; 25:387-394.
11. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N EnglJ Med. 1995;332:977-982.
12. Guallar E, Aro A, Jimenez FJ, et al. Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: the EURAMIC study. Arterioscler Thromb Vase Biol. 1999;19:1111-1118.
13. Seidelin KN, Myrup B, Fischer-Hansen B. n-3 Fatty acids in adipose tissue and coronary artery disease are inversely related. Am J Clin Nutr. 1992;55:1117-1119.
14. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279:23-28.
15. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274:1363-1367.
16. Landmark K, Abdelnoor M, Urdal P, et al. Use of fish oils appears to reduce infarct size as estimated from peak creatine kinase and lactate dehydrogenase activities. Cardiology. 1998;89:94-102.
17. Landmark K, Abdelnoor M, Kilhovd B, Dorum HP. Eating fish may reduce infarct size and the occurrence of Q wave infarcts. Eur J Clin Nutr. 1998;52:40-44.
18. Gruppo Italiano per lo Studio della Sopravvivenza neH'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455.
19. Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339: 1349-1357.
20. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial. Lancet. 1989;2:757-761.
21. Burr ML, Sweetham PM, Fehily AM. Diet and reinfarction [letter]. Eur Heart J. 1994;15:1152-1153.
22. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and i mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther. 1997; 11:485-491.
23. Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC, HARP Research Group. Controlled trial of fish oil for regression of human coronary atherosclerosis. / Am Coll Cardiol. 1995;25:1492-1498.
24. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary ω-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999:130:554-562.
25. Fauchier L, Babuty D, Cosnay P, Fauchier JP. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. / Am Coll Cardiol. 1999;33:1203-1207.
26. Christensen JH, Gustenhoff P, Korup E, et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ. 1996;312:677-678.
27. Sellmayer A, Witzgall H, Lorenz R, Weber PC. Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol. 1995; 76:974-977.
28. O'Connor GT, Malenka DJ, Olmstead EM, Johnson PS, Hennekens CH. A meta-analysis of randomized trials of fish oil in prevention of restenosis following coronary angioplasty. AmJ Prev Med. 1992;8:186-192.
29. Bairati I, Roy L, Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation. 1992;85:950-956.
30. Leaf A, Jorgensen MB, Jacobs AK, et al. Do fish oils prevent restenosis after coronary angioplasty? Circulation. 1994;90:22482257.
31. Cairns JA, Gill J, Morton B, et al. Fish oils and low-molecularweight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty: the EMPAR study. Circulation. 1996;94:1553-1560.
32. Eritsland J, Amesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol. 1996:77:31-36.
33. Salem N Jr, Wegher B, Mena P, Uauy RD. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. ProcNatlAcadSci USA. 1996;93:4954.
34. Marangoni F, Angeli MT, Colli S, et al. Changes of n-3 and -6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta. 1993; 1210: 55-62.
35. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M, Willett WC. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ. 1996;313: 84-90.
36. Hu FB, Stampfer MJ, Manson JE, et al. Dietary intake of alinolenic acid and risk of fatal ischémie heart disease among women. Am J Clin Nutr. 1999;69:890-897.
37. de Lorgeril M, Sälen P, Martin JL, Monjaud I, Délaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999:99:779-785.
38. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alphalinolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454-1459.
39. Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sei USA. 1994:91:4427-4430.
40. Leaf A, Kang JX. Prevention of cardiac sudden death by N-3 fatty acids: a review of the evidence. J Intern Med. 1996;240:5-12.
41. Gulp BR, Lands WE, Lucches BR, Pitt B, Romson J. The effect of dietary supplementation of fish oil on experimental myocardial infarction. Prostaglandins. 1980;20:1021-1031.
42. Hock CE, Holahan MA, Reibel DK. Effect of dietary fish oil on myocardial phospholipids and myocardial ischémie damage. AmJ Physiol. 1987;252:H554-H560.
43. McLennan PL, Abeywardena MY, Chamock JS. Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J. 1988;! 16:709-717.
44. Hock CE, Beck LD, Bodine RC, Reibel DK. Influence of dietary n3 fatty acids on myocardial ischemia and reperfusion. AmJ Physiol. 1990;259:H1518-H1526.
45. Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure ω-3 polyunsaturated fatty acids in dogs. Circulation. 1999:99:2452-2457.
46. Kang JX, Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids: recent studies. Circulation. 1996:94:1774-1780.
47. Lands WE. n-3 Fatty acids as precursors for active metabolic substances: dissonance between expected and observed events. / Intern Med Suppl. 1989;225:11-20.
48. Ridker PM. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation. 1998:97:1671-1674.
49. DeCaterina R, Giannessi D, Mazzone A, et al. Vascular prostacyclin is increased in patients ingesting ω-3 polyunsaturated fatty acids before coronary artery bypass graft surgery. Circulation. 1990;82:428-438.
50. Lands WEM. Fish and Human Health. Orlando, Fla: Academic Press; 1986.
51. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb VascBiol. 1997;17:1859-1867.
52. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med. 1985;312:1217-1224.
53. Simopoulos AP, Robinson J. The Omega Diet: The Lifesaving Nutritional Program Based on the Diet of the Island of Crete. New York, NY: HarperCollins Publishers, Inc; 1999.
54. Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr. 1997; 65:1011-1017.
55. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis on interleukin-1 and tumor necrosis factor by mononuclear cells. N EnglJ Med. 1989;320:265-271.
56. Belluzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses on Crohn 's disease. N EnglJ Med. 1996;334:1557-1560.
57. Stenson WE, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med. 1992; 116:609-614.
58. Kremer JM, Lawrence DA, Petrillo GF, et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs: clinical and immune correlates. Arthritis Rheum. 1995;38:1107-1114.
59. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE, Mayo Nephrology Collaborative Group. A controlled trial of fish oil inlgAnephropathy.NEnglJMed. 1994;331:1194-1199.
60. Miller M, Siedler A, Moalemi A, Pearson TA. Normal triglycéride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. / Am Coll Cardiol. 1998;31: 1252-1257.
61. Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65(suppl):1645S-1654S.
62. Harris WS, Ginsberg HN, Arunakul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk. 1997;4: 385-391.
63. Röche HM, Gibney MJ. Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation. EurJClin Nutr. 1996;50:617-624.
64. Bjorkegren J, Boquist S, Samnegard A, et al. Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease. Circulation. 2000; 101:227230.
65. Leaf A. Cardiovascular effects of fish oils: beyond the platelet. Circulation. 1990;82:624-628.
66. Schmidt EB, Dyerberg J. Omega-3 fatty acids: current status in cardiovascular medicine. Drugs. 1994;47:405-424.
67. McVeigh GE, Brennan GM, Cohn JN, Finkelstein SM, Hayes RJ, Johnston GD. Fish oil improves arterial compliance in non-insulindependent diabetes mellitus. Arterioscler Thromb. 1994; 14:14251429.
68. Chin JP, Gust AP, Nestel PJ, Dart AM. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension. 1993;21:22-28.
69. Harris WS, Rambjor GS, Windsor SL, Diederich D. n-3 Fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J ClinNutr. 1997;65:459-464.
70. Contacos C, Barter PJ, Sullivan DR. Effect of pravastatin and ω-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arterioscler Thromb. 1993;13:1755-1762.
71. Goodnight SH Jr, Harris WS, Connor WE. The effects of dietary omega-3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood. 1981;58:880-885.
72. Knapp HR: Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr. 1997;65(suppl):1687S-1698S.
73. Glauber H, Wallace P, Griver K, Brechtel G. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1988; 108:663-668.
74. Axelrod L, Camuso J, Williams E, Kleinman K, Briones E, Schoenfeld D. Effects of a small quantity of 00-3 fatty acids on cardiovascular risk factors in NIDDM: a randomized, prospective, double-blind, controlled study. Diabetes Care. 1994; 17:37-44.
75. Rivellese AA, Maffettone A, lovine C, et al. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care. 1996; 19:12071213.
76. Sirtori CR, Paoletti R, Mancini M, et al. n-3 Fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance: Italian Fish Oil Multicenter Study. Am J ClinNutr. 1997;65:1874-1881.
77. Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE. Fish oil and glycémie control in diabetes: a meta-analysis. Diabetes Care. 1998; 21:494-500.
78. Substances affirmed as generally recognized as safe: menhaden oil. Fed Regist. June 5, 1997;62:30751-30757.
79. Hepburn FN, Exler J, Weihrauch JL. Provisional tables on the content of omega-3 fatty acids and other fat components of selected foods. J Am DietAssoc. 1986;86:788-793.
80. Mackness MI, Bhatnagar D, Durrington PN, et al. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. EurJClin Nutr. 1994;48:859-865.
81. Nordoy A, Bonaa KH, Nilsen H, Berge RK, Hansen JB, Ingebretsen OC. Effects of simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia. J Intern Med. 1998;243:163-170.
82. Hansen JB, Grimsgaard S, Nilsen H, Nordoy A, Bonaa KH. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia. Lipids. 1998;33:131-138.
83. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr. 1997;66:649-659.
84. Boa DQ, Mori TA, Burke V, Puddey IB, Beilin LJ. Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension. 1998;32:710-717.
85. Grimsgaard S, Bonaa KH, Hansen JB, Myhre ES. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr. 1998;68:52-59.